Companies: 10,795·Total market cap: $144.5T

Addex Therapeutics Ltd

Addex Therapeutics Ltd

ADXNNASDAQHealthcare● Active

$6.90

+$1.04(+17.75%)

Market Cap$4969725

P/E Ratio—

52W High$12.05

52W Low$5.41

Avg Volume4K

Open$6.58

Beta1.97

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Addex Therapeutics Ltd（ADXN）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · ADXN · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-7.57Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)66347.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding935,000Shares outstanding history

Next EarningsJun 15, 2026Est.Earnings history

探索 Addex Therapeutics Ltd 数据

分析师预测$30 · Buy

股息不分红

营收$29972-92.58%

盈利EPS $-6.88-181.90%

财务快照

FY 2025Revenue$29972.00▼ 92.58% YoY

202320242025

FY 2025Net Income-$6.7M▼ 195.36% YoY

202320242025

FY 2025EPS$-6.88▼ 181.90% YoY

202320242025

TTM:Revenue: $66347.00Net Income: -$6.7MEPS: $-7.57View income statement →

分析师评级与目标价

Buy1 位分析师

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$30.00Low

$6.90Current

$30.00Avg Target上涨空间 334.78%

$30.00High

合计: 1 · 买入占比: 100.0%

根据过去 3 个月内 1 位华尔街分析师，ADXN 共识评级为 Buy，12 个月平均目标价 $30.00 （较现价 $6.90 上涨空间 334.78%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Addex Therapeutics Ltd

$6.90+17.75%$5.0M #2

Adial Pharmaceuticals, Inc.

$2.21+0.00%$2.1M #3

Brainstorm Cell Therapeutics Inc.

$0.80+6.87%$8.8M #4

Cardio Diagnostics Holdings, Inc.

$1.99+1.53%$4.1M #5

Impact BioMedical Inc.

$0.56-1.27%$7.0M #6

Matinas BioPharma Holdings, Inc.

$0.83+5.20%$4.6M

股票表现

1D+17.75%

1W+7.81%

1M+0.88%

3M-3.77%

YTD-10.62%

1Y-31.41%

5Y-96.68%

关于 Addex Therapeutics Ltd

CEOTimothy Mark Dyer

IPO DateFeb 12, 2020

Employees2

CountryCH

Websiteaddextherapeutics.com

Addex Therapeutics Ltd a biopharmaceutical firm in a developmental phase, operates out of Switzerland, focusing on the discovery, advancement, and commercialization of small-molecule drugs targeting …

Biotechnology HealthcareNASDAQADRCH

关于股票概览与关键数据

Addex Therapeutics Ltd（ADXN）是 Biotechnology 行业的 Healthcare 类公司，于 Feb 12, 2020 在 NASDAQ 上市。截至最近交易日，ADXN 股价为 $6.90，市值约为 $5.0M。过去12个月累计回报 -31.41%，年初至今回报 -10.62%。

根据 1 位华尔街分析师，Addex Therapeutics Ltd 股票共识评级为Buy，12个月平均目标价为 $30.00。2025 财年 Addex Therapeutics Ltd 营收 $29972.00，净利润 -$6.7M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Addex Therapeutics Ltd（ADXN）股价为 $6.90，在 NASDAQ 上市，52周区间为 $5.41 – $12.05。

ADXN 最新股价ADXN quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议